DR.Chip Biotechnology Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2022
May 09, 2022 at 05:12 pm EDT
DR.Chip Biotechnology Incorporation reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 28.82 million compared to TWD 24.99 million a year ago. Revenue was TWD 28.82 million compared to TWD 24.99 million a year ago. Net loss was TWD 3.94 million compared to TWD 2.53 million a year ago. Basic loss per share from continuing operations was TWD 0.21 compared to TWD 0.13 a year ago. Diluted loss per share from continuing operations was TWD 0.21 compared to TWD 0.13 a year ago.